- Home
- CMMB vs CMBM Comparison
CMMB vs CMBM Comparison
Compare CMMB & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- CMBM
- Stock Information
- Founded
- CMMB 2004
- CMBM 2011
- Country
- CMMB Israel
- CMBM United States
- Employees
- CMMB N/A
- CMBM N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- CMMB Health Care
- CMBM Technology
- Exchange
- CMMB Nasdaq
- CMBM Nasdaq
- Market Cap
- CMMB 23.6M
- CMBM 21.6M
- IPO Year
- CMMB N/A
- CMBM 2019
- Fundamental
- Price
- CMMB $1.16
- CMBM $0.36
- Analyst Decision
- CMMB Strong Buy
- CMBM Strong Buy
- Analyst Count
- CMMB 2
- CMBM 2
- Target Price
- CMMB $9.00
- CMBM $5.50
- AVG Volume (30 Days)
- CMMB 153.9K
- CMBM 250.3K
- Earning Date
- CMMB 03-03-2025
- CMBM 05-08-2025
- Dividend Yield
- CMMB N/A
- CMBM N/A
- EPS Growth
- CMMB N/A
- CMBM N/A
- EPS
- CMMB N/A
- CMBM N/A
- Revenue
- CMMB N/A
- CMBM $172,215,000.00
- Revenue This Year
- CMMB N/A
- CMBM N/A
- Revenue Next Year
- CMMB N/A
- CMBM $16.82
- P/E Ratio
- CMMB N/A
- CMBM N/A
- Revenue Growth
- CMMB N/A
- CMBM N/A
- 52 Week Low
- CMMB $0.58
- CMBM $0.29
- 52 Week High
- CMMB $2.55
- CMBM $4.45
- Technical
- Relative Strength Index (RSI)
- CMMB 31.89
- CMBM 28.31
- Support Level
- CMMB $0.92
- CMBM $0.29
- Resistance Level
- CMMB $1.35
- CMBM $0.88
- Average True Range (ATR)
- CMMB 0.12
- CMBM 0.08
- MACD
- CMMB -0.01
- CMBM -0.03
- Stochastic Oscillator
- CMMB 24.79
- CMBM 10.52
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.